Document is current
Any future updates will be listed below
-
Authors
Lai, Yongrong https://orcid.org/0000-0002-0371-1719
Liu, Rongrong
Wang, Lijie
Ma, Xu-Kai
Li, Yaliang
Yang, Gaohui
Shi, Lingling
Guo, Yi-Lin
Wei, Zhenbin
Zhou, Xuemei
Xu, Wenchao
Hou, Yaofeng
Miccio, Annarita https://orcid.org/0000-0002-3409-9665
Yang, Bei https://orcid.org/0000-0001-5389-3859
Mou, Xiaodun https://orcid.org/0009-0007-5449-712X
Yang, Li https://orcid.org/0000-0001-8833-7473
Chen, Jia https://orcid.org/0000-0002-4242-2899
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 27 February 2026
First Online: 8 April 2026
Competing interests
: J.C., L.Y. and B.Y. are scientific cofounders of CorrectSequence Therapeutics, a company that uses gene-editing technologies, and the members of its scientific advisory board. X.M., L.W. and Y. Li are employees of CorrectSequence Therapeutics. The remaining authors declare no competing interests.
